Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 8mg	8mg	Tablet, scored	434,061 L.L
J01MA02	CIPROLON 500	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film coated	295,645 L.L
N07CA02	CINARIN	G	Cinnarizine - 75mg	75mg	Capsule	490,183 L.L
A11CC05	CHOLECALCIFEROL BIOGARAN	G	Vitamin D3 - 100,000UI/2ml	100,000UI	Solution	115,570 L.L
B05D	CAPD/DPCA 2Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Glucose monohydrate - 16.5g/l		Injectable solution	735,741 L.L
J01MA02	CIPROMAX	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film coated	392,402 L.L
N07CA02	CINNARIZINE	G	Cinnarizine - 75mg	75mg	Capsule	386,515 L.L
B05D	CAPD/DPCA 3Solution for peritoneal dialysis	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 42.50g/l, Glucose monohydrate - 46.75g/l		Injectable solution	769,337 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
J01MA02	CIPROMID	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film coated	331,929 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	744,140 L.L
J01MA02	CIPROPHARM	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film-scored	354,774 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	2,303,346 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	744,140 L.L
N03AG01	CONVULEX	G	Sodium Valproate - 50mg/ml	50mg/ml	Syrup	213,671 L.L
N07X	CEREBROLYSIN	G	Cerebrolysin - 215.2mg/ml	215.2mg/ml	Injectable concentrated solution	3,886,393 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 16mg	16mg	Tablet, scored	434,061 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 32mg	32mg	Tablet, scored	434,061 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacine (HCl) - 200mg/100ml	200mg/100ml	Injectable solution	5,120,040 L.L
N03AG01	CONVULEX	G	Sodium Valproate - 300mg/ml	300mg/ml	Solution	1,018,633 L.L
S02AA15	CETRAXAL OTICO	G	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops	821,088 L.L
J01DB04	CEFAZOL IM/IV	G	Cefazolin (sodium) - 1g	1g	Injectable powder	5,375,370 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacine (HCl) - 200mg/100ml	200mg/100ml	Injectable solution	5,120,040 L.L
J01DB04	CEFAZOLIN PANPHARMA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	5,521,849 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacin - 200mg/100ml	200mg/100ml	Injectable solution	4,914,432 L.L
J01DB04	CEFAZOLINA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	18,574,396 L.L
J01MA02	CIPROLON 200	G	Ciprofloxacin (lactate) - 200mg/100ml	200mg/100ml	Injectable solution	686,704 L.L
M01AB05	CLOREN	G	Diclofenac sodium - 12.5mg	12.5mg	Suppository	353,239 L.L
J01DB04	CEFAZOLINE LDP-LABORATORIOS TORLAN	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	1,631,425 L.L
J01MA02	CIPROX	G	Ciprofloxacine (lactate) - 200mg/100ml	0.2%w/v	Injectable solution	520,067 L.L

...